American Association for Cancer Research Annual Meeting

The latest news from AACR, including researcher interviews and physician perspective.

Meeting News Coverage

CDK inhibitor shows promise in metastatic breast cancer

April 7, 2014
The oral drug LY2835219 demonstrated encouraging activity as single-agent therapy for patients with metastatic breast cancer, according to study…
Meeting News Coverage

Palbociclib plus letrozole extended PFS in metastatic breast cancer

April 7, 2014
The addition of palbociclib to letrozole during first-line treatment significantly extended PFS in post-menopausal patients with ER-positive…
Cover Story

Despite headlines, role of statins in cancer prevention far from proven

HemOnc Today, May 25, 2013
The potential role of statins in cancer prevention has received tremendous attention from the medical research community and the media.
Cover Story

Nanoparticles offer ‘infinite’ possibilities for cancer treatment

HemOnc Today, May 10, 2013
After more than 3 decades of intense research, nanotechnology has moved out of the fiction realm and into the scientific.
Meeting News Coverage

Exercise lowered estrogens, breast cancer risk in postmenopausal women

April 24, 2013
Results of a study presented at the American Association for Cancer Research Annual Meeting have given researchers a better idea of the potential…
Meeting News Coverage

Omega-3 fatty acids slowed growth of triple-negative breast cancer

April 11, 2013
Omega-3 fatty acids have the potential to delay or halt the growth of triple-negative breast cancer cells, according to researchers at Fox Chase…
Meeting News CoveragePerspective

Some melanoma survivors fail to wear sunscreen, still use tanning beds

April 8, 2013
More than one-quarter of melanoma survivors never wear sunscreen when outside for extended periods, according to findings presented at the AACR…
Meeting News Coverage

Combination treatment may benefit NSCLC patients ineligible for bevacizumab

April 9, 2012
Patients with non–small cell lung cancer who are not eligible for treatment with bevacizumab may benefit from treatment with a combination of…
In the Journals

NHANES: Nearly half of cancer survivors died from other conditions

April 9, 2012
Almost half of the cancer survivors evaluated in a recent study died from conditions other than cancer, such as cardiovascular and respiratory…
In the JournalsPerspective

Older women with luminal A breast cancer may not need radiation

April 4, 2012
Women aged at least 60 years with luminal A breast cancer had lower rates of relapse when they did not undergo radiation treatment. At 10-year…